Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Accumulated Expenses: 2010-2019

Historic Accumulated Expenses for Neurocrine Biosciences (NBIX) over the last 6 years, with Dec 2019 value amounting to $38.9 million.

  • Neurocrine Biosciences' Accumulated Expenses rose 42.43% to $38.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was $38.9 million, marking a year-over-year increase of 42.43%. This contributed to the annual value of $38.9 million for FY2019, which is 42.43% up from last year.
  • According to the latest figures from Q4 2019, Neurocrine Biosciences' Accumulated Expenses is $38.9 million, which was up 42.43% from $27.3 million recorded in Q4 2018.
  • In the past 5 years, Neurocrine Biosciences' Accumulated Expenses registered a high of $38.9 million during Q4 2019, and its lowest value of $9.6 million during Q4 2016.
  • Moreover, its 3-year median value for Accumulated Expenses was $26.1 million (2017), whereas its average is $27.4 million.
  • Per our database at Business Quant, Neurocrine Biosciences' Accumulated Expenses slumped by 49.78% in 2016 and then surged by 160.50% in 2017.
  • Over the past 5 years, Neurocrine Biosciences' Accumulated Expenses (Quarterly) stood at $19.0 million in 2015, then plummeted by 49.78% to $9.6 million in 2016, then spiked by 160.50% to $24.9 million in 2017, then grew by 9.80% to $27.3 million in 2018, then surged by 42.43% to $38.9 million in 2019.
  • Its Accumulated Expenses stands at $38.9 million for Q4 2019, versus $27.3 million for Q4 2018 and $24.9 million for Q4 2017.